Once worth $6 billion, 23andMe has lost 98% of its value and is on the verge of being delisted from the Nasdaq. So what happened?

After a large data breach in 2023, the value of 23andMe has plummeted, prompting concerns that the company — and all its users’ genetic data — could soon be up for sale.

After a large data breach in 2023, the value of 23andMe has plummeted, prompting concerns that the company — and all its users’ genetic data — could soon be up for sale. NBC 5 Responds’ PJ Randhawa reports.

In a memo to employees on Tuesday, 23andMe CEO Anne Wojcicki said the company will search for new directors.

23andMe CEO Anne Wojcicki has submitted a proposal to take the genetic testing company private.

23andMe CEO Anne Wojcicki is considering a proposal to take the genetic testing company private.

CVS, Humana and other insurers are getting dogged by higher medical costs. Meanwhile, 23andMe has a tough road ahead.

23andMe reported dismal third-quarter fiscal 2024 results and discussed splitting itself in two to help juice its stock price.

Genetic testing company 23andMe said Monday that hackers were able to access the data of about 6.9 million people, far more than the company previously acknowledged.

Hackers have compiled a giant apparent list of people with Ashkenazi Jewish ancestry after taking that information from the genetic testing service 23andMe, which is now being shared on the internet.